Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
VCU Massey Cancer Center P01 Pilot
Grant: NIH-NCI R21 CA259782
VCU Massey Cancer Center P01 Pilot
Grant: R01 CA239706
VCU Massey Cancer Center P01 Pilot
Grant: P30 CA016059
National Institutes of Health
Grant: 1R21CA259782-01A1
Targeting gain-of-function p53 and BCL-2 for small cell lung cancer treatment
National Institutes of Health
Grant: 5R01CA239706-03
Use of senolytics to enhance chemotherapeutic efficacy in lung cancer
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
FWCI
1.27
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals